http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2547731-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
filingDate 1983-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aca51d2532659316060c35d26909ea05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddc0d9db2eed72d469aa1474bf5645e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9387efc3e6180ed0962bc1bd4eb6e5c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef44634f239e9b6904c70fddd8b850fe
publicationDate 1984-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2547731-A1
titleOfInvention ANTITUMOR IMMUNOTOXIN, PHARMACEUTICAL PREPARATIONS CONTAINING IT AND ITS USE IN VITRO
abstract THE IMMUNOTOXIN ACCORDING TO THE INVENTION ESSENTIALLY CONSISTS OF AN ANTIBODY, PREFERRED MONOCLONAL, SPECIFIC TO GLOBOTRIAOSYLCERAMIDE, OR CERAMIDETRIHEXOSYL, OF STRUCTURE: GALA (14) GALB (14) GLCB (11) WITH CERAMIDE, OR ANTIOCGENE WITH CTH, OR ANTIOCGENE CONDITIONS ALLOWING THE INTERNALIZATION OF THE TOXIN IN ANIMAL CELLS. THIS IMMUNOTOXIN CAN BE USED BOTH IN VITRO AND IN VIVO FOR THE DESTRUCTION OF MALIGNANT CELLS CARRYING THE CTH ANTIGEN, EVEN IN QUANTITIES NOT DETRICABLE BY KNOWN PRECISE METHODS OF ANALYSIS.
priorityDate 1983-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4356117-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0080401-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0023401-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0063988-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2466252-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0044167-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00587
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID820085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451984396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66616222
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID100682
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100277053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21333
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57383916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422154253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426285987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6372196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415721994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36511
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID819276
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02879
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426100422
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5PY51
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139708584
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00588

Total number of triples: 54.